Literature DB >> 29363944

Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.

Katlyn A Fleming1, Mark D Ericson1, Katie T Freeman1, Danielle N Adank1, Mary M Lunzer1, Stacey L Wilber1, Carrie Haskell-Luevano1.   

Abstract

The melanocortin system has five receptors, and antagonists of the central melanocortin receptors (n class="Gene">MC3R, MC4R) are postulated to be viable therapeutics for disorders of negative energy balance such as anorexia, cachexia, and failure to thrive. Agouti-related protein (AGRP) is an antagonist of the MC3R and an antagonist/inverse agonist of the MC4R. Biophysical NMR-based structural studies have demonstrated that the active sequence of this hormone, Arg-Phe-Phe, is located on an exposed β-hairpin loop. It has previously been demonstrated that the macrocyclic octapeptide scaffold c[Pro1-Arg2-Phe3-Phe4-Asn5-Ala6-Phe7-DPro8] is 16-fold less potent than AGRP at the mouse MC4R (mMC4R). Herein it was hypothesized that the Phe7 position may be substituted to produce more potent and/or selective melanocortin receptor antagonist ligands based on this template. A 10-membered library was synthesized that substituted small (Gly), polar (Ser), acidic (Asp), basic (Lys), aliphatic (Leu, Nle, and Cha), and aromatic (Trp, Tyr, hPhe) amino acids to explore potential modifications at the Phe7 position. The most potent mMC4R antagonist contained a Nle7 substitution, was equipotent to the lead ligand 200-fold selective for the mMC4R over the mMC3R, and caused a significant increase in food intake when injected intrathecally into male mice. Three compounds possessed sigmoidal dose-response inverse agonist curves at the mMC5R, while the remaining seven decreased cAMP production from basal levels at a concentration of 100 μM. These findings will add to the knowledge base toward the development of potent and selective probes to study the role of the melanocortin system in diseases of negative energy balance and can be useful in the design of molecular probes to examine the physiological functions of the mMC5R.

Entities:  

Keywords:  AGRP; IT; food intake; melanocortin receptors; structure−activity relationships

Mesh:

Substances:

Year:  2018        PMID: 29363944      PMCID: PMC5955836          DOI: 10.1021/acschemneuro.7b00495

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  62 in total

1.  Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man.

Authors:  A B LERNER; J S MCGUIRE
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

2.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

3.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

4.  Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.

Authors:  Mark D Ericson; Andrzej Wilczynski; Nicholas B Sorensen; Zhimin Xiang; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2015-04-21       Impact factor: 7.446

5.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

6.  Structures of the agouti signaling protein.

Authors:  Joseph C McNulty; Pilgrim J Jackson; Darren A Thompson; Biaoxin Chai; Ira Gantz; Gregory S Barsh; Philip E Dawson; Glenn L Millhauser
Journal:  J Mol Biol       Date:  2005-01-25       Impact factor: 5.469

7.  An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Danielle N Adank; Robert C Speth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2016-03-29       Impact factor: 7.446

8.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.

Authors:  D Lu; D Willard; I R Patel; S Kadwell; L Overton; T Kost; M Luther; W Chen; R P Woychik; W O Wilkison
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

9.  Contribution of melanocortin receptor exoloops to Agouti-related protein binding.

Authors:  Y K Yang; C J Dickinson; Q Zeng; J Y Li; D A Thompson; I Gantz
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

10.  Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation.

Authors:  M W Miller; D M Duhl; H Vrieling; S P Cordes; M M Ollmann; B M Winkes; G S Barsh
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

View more
  7 in total

1.  Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.

Authors:  Katlyn A Fleming; Katie T Freeman; Mike D Powers; Radleigh G Santos; Ginamarie Debevec; Marc A Giulianotti; Richard A Houghten; Skye R Doering; Clemencia Pinilla; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2019-02-28       Impact factor: 7.446

2.  Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.

Authors:  Mark D Ericson; Zoe M Koerperich; Katie T Freeman; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-07-20       Impact factor: 4.418

3.  Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.

Authors:  Zoe M Koerperich; Mark D Ericson; Katie T Freeman; Robert C Speth; Irina D Pogozheva; Henry I Mosberg; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2020-01-06       Impact factor: 7.446

4.  Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Robert C Speth; Adam T Zarth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2018-05-09       Impact factor: 7.446

5.  Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.

Authors:  Katlyn A Fleming; Katie T Freeman; Mark D Ericson; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2018-08-16       Impact factor: 7.446

Review 6.  A Review of Single-Nucleotide Polymorphisms in Orexigenic Neuropeptides Targeting G Protein-Coupled Receptors.

Authors:  Mark D Ericson; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

7.  Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist Pharmacology at the hMC4R.

Authors:  Mark D Ericson; Erica M Haslach; Sathya M Schnell; Katie T Freeman; Zhimin M Xiang; Frederico P Portillo; Robert Speth; Sally A Litherland; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2021-01-20       Impact factor: 4.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.